The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quantitative detection of the T790M EGFR mutation in circulating tumor DNA of lung cancer patients subjected to EGFR-TKI treatment.
J. Uchida
No relevant relationships to disclose
K. Taniguchi
No relevant relationships to disclose
F. Imamura
No relevant relationships to disclose
K. Nishino
No relevant relationships to disclose
T. Kumagai
No relevant relationships to disclose
Y. Akazawa
No relevant relationships to disclose
T. Okuyama
No relevant relationships to disclose
K. Kato
No relevant relationships to disclose